Home » Topics » BioWorld Science

BioWorld Science
RSS

New mutation in SLC20A2 gene found in Fahr's disease

May 7, 2018

ORR data from KEYNOTE-407 trial of Keytruda in first-line NSCLC support sBLA submission

May 7, 2018

Charles River Laboratories extends collaboration with Michael J. Fox Foundation

May 7, 2018

Novel ELOVL4 gene mutation tied to spinocerebellar ataxia with retinitis pigmentosa

May 7, 2018

monARC Bionetworks begins strategic integration with Roivant drug development platform

May 7, 2018

Lilly initiates phase III study of mirikizumab in moderate to severe plaque psoriasis

May 7, 2018

FDA grants priority review to Tecentriq sBLA for first-line treatment of metastatic NSCLC

May 7, 2018

Evolve doses first pediatric patient in phase III trial of PlasmaCap IG

May 7, 2018

Sage Therapeutics identifies GluN2A and/or GluN2B NAMs

May 7, 2018

Isofol receives FDA feedback on SPA for pivotal study of arfolitixorin in colorectal cancer

May 7, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...